Multiple sclerosis: The role of melatonin and N-acetylserotonin

Multiple Sclerosis and Related Disorders

Volumn 4, Issue 2, 2015, Pages 112-123

  Anderson, George ^a   Rodriguez, Moses ^b  

^a CRC Scotland and London   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Depression; Melatonin; Mitochondria; Multiple sclerosis; N Acetylserotonin; Remyelination

Indexed keywords

APOLIPOPROTEIN E4; BETA INTERFERON; FINGOLIMOD; GLATIRAMER; LEPTIN; LITHIUM SALT; MELATONIN; N ACETYLSEROTONIN; SEROTONIN; SUBSTANCE P; VALPROIC ACID; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; LITHIUM DERIVATIVE; N-ACETYLSEROTONIN; NOOTROPIC AGENT;

ARTICLE; ASTROCYTE; COGNITIVE DEFECT; DEMYELINATION; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLIA; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; MITOCHONDRION; MULTIPLE SCLEROSIS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; REMYELINIZATION; WHITE MATTER; ANALOGS AND DERIVATIVES; PHYSIOLOGY;

FINGOLIMOD HYDROCHLORIDE; GLATIRAMER ACETATE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; LITHIUM COMPOUNDS; MELATONIN; MULTIPLE SCLEROSIS; NOOTROPIC AGENTS; SEROTONIN; VALPROIC ACID;

EID: 84924978163     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2014.12.001     Document Type: Article

References (149)

1. Z. Akpinar, S. Tokgöz, H. Gökbel, N. Okudan, F. Uʇuz, and G. Yilmaz The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis (Nov 30) Psychiatry Res 161 2 2008 253 257
2. E. Alcalde-Cabero, J. Almazán-Isla, A. García-Merino, J. de Sá, and J. de Pedro-Cuesta Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring (Jun 12) BMC Neurol 2013 13 58
3. Anderson G, Maes M. The gut-brain axis: the role of melatonin in linking psychiatric, inflammatory and neurodegenerative conditions. Adv Integr Med in press.
4. G. Anderson, and M. Maes Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders CNS Neurol Disord Drug Targets 13 5 2014 817 827
5. G. Anderson, and M. Maes Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications Curr Pharm Des 20 23 2014 3812 3847
6. G. Anderson, and M. Maes TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease (Feb) CNS Neurol Dis 13 1 2014 137 149
7. G. Anderson, M. Maes, and M. Berk Biological underpinnings of the commonalities in depression, somatization, and chronic fatigue syndrome Med Hypotheses 78 2012 752 756
8. G. Anderson, M. Maes, and M. Berk Inflammation-related disorders in the tryptophan catabolite (TRYCAT) pathway in depression and somatization Adv Protein Chem Struct Biol 88 2012 27 48
9. G. Anderson Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination Med Hypotheses. 76 2011 54 60
10. G. Anderson, and M. Rodriguez Multiple sclerosis, seizures and anti-epileptics: role of IL-18, IDO and melatonin (May) Eur J Neurol 18 5 2011 680 685
11. G. Anderson, and J.O. Ojala Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic acid Int J Trytophan Res 3 2010 169 173
12. G. Bartzokis, P.H. Lu, D.H. Geschwind, K. Tingus, D. Huang, and M.F. Mendez Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia (Dec 15) Biol Psychiatry. 62 12 2007 1380 1387
13. B. Ben-Zeev, R. Aharoni, A. Nissenkorn, and R. Arnon Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome Med Hypotheses. 76 2 2011 Feb 190 193
14. M. Bernard, and P. Voisin Photoreceptor-specific expression, light-dependent localization, and transcriptional targets of the zinc-finger protein Yin Yang 1 in the chicken retina (May) J Neurochem. 105 3 2008 595 604
15. J.F. Bogie, S. Timmermans, V.A. Huynh-Thu, A. Irrthum, H.J. Smeets, and J.Å. Gustafsson Myelin-derived lipids modulate macrophage activity by liver X receptor activation PLoS One 7 9 2012 e44998
16. M. Cambron, M. D'Haeseleer, G. Laureys, R. Clinckers, J. Debruyne, and J. De Keyser White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis (Mar) J Cereb Blood Flow Metab. 32 3 2012 413 424
17. B.M. Campbell, E. Charych, A.W. Lee, and T. Möller Kynurenines in CNS disease: regulation by inflammatory cytokines (Feb) Front Neurosci 6 2014 8 12
18. G.R. Campbell, N. Ohno, D.M. Turnbull, and D.J. Mahad Mitochondrial changes within axons in multiple sclerosis: an update (Jun) Curr Opin Neurol. 25 3 2012 221 230
19. S. Carloni, M.C. Albertini, L. Galluzzi, G. Buonocore, F. Proietti, and W. Balduini Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia (Sep) J Pineal Res. 57 2 2014 192 199
20. L.M. Castro, M. Gallant, and L.P. Niles Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells J Neurochem. 95 2005 1227 1236
21. Y.C. Chen, J.M. Sheen, Y.L. Tain, C.C. Chen, M.M. Tiao, and Y.H. Huang Alterations in NADPH oxidase expression and blood-brain barrier in bile duct ligation-treated young rats: effects of melatonin (Jun) Neurochem Int. 60 8 2012 751 758
22. W. Chen, X. Liang, A.J. Peterson, D.H. Munn, and B.R. Blazar The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation (Oct 15) J Immunol. 181 8 2008 5396 5404
23. T.Y. Chen, M.Y. Lee, H.Y. Chen, Y.L. Kuo, S.C. Lin, and T.S. Wu Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice (Apr) J Pineal Res. 40 3 2006 242 250
24. M.R. Choi, S. Hwang, G.M. Park, K.H. Jung, S.H. Kim, and N.D. Das Effect of fluoxetine on the expression of tryptophan hydroxylase and 14-3-3 protein in the dorsal raphe nucleus and hippocampus of rat (Mar) J Chem Neuroanat. 43 2 2012 96 102
25. J.W. Choi, S.E. Gardell, D.R. Herr, R. Rivera, C.W. Lee, and K. Noguchi FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation (Jan 11) Proc Natl Acad Sci USA. 108 2 2011 751 756
26. J.R. Christensen, L. Börnsen, R. Ratzer, F. Piehl, M. Khademi, and T. Olsson Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression PLoS One 8 3 2013 e57820
27. S.J. Clokie, P. Lau, H.H. Kim, S.L. Coon, and D.C. Klein MicroRNAs in the pineal gland: miR-483 regulates melatonin synthesis by targeting arylalkylamine N-acetyltransferase (Jul 20) J Biol Chem. 287 30 2012 25312 25324
28. E. Colombo, M. Di Dario, E. Capitolo, L. Chaabane, J. Newcombe, and G. Martino Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide (Sep) Ann Neurol. 76 3 2014 325 337
29. H.C. Comijs, T.N. van den Kommer, R.W. Minnaar, B.W. Penninx, and D.J. Deeg Accumulated and differential effects of life events on cognitive decline in older persons: depending on depression, baseline cognition, or ApoE epsilon4 status? (Jul) J Gerontol B Psychol Sci Soc Sci 66 Suppl 1 2011 i111 i120
30. Cox A.J., West N.P., Cripps A.W. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. in press.
31. T.G. D'Aversa, E.A. Eugenin, L. Lopez, and J.W. Berman Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis (Apr) Neuropathol Appl Neurobiol. 39 3 2013 270 283
32. W. Davis, S.J. van Rensburg, F.J. Cronje, L. Whati, L.R. Fisher, and L. van der Merwe The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors (Jun) Metab Brain Dis. 29 2 2014 409 419
33. J. De Keyser, G. Laureys, F. Demol, N. Wilczak, J. Mostert, and R. Clinckers Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis (Nov) Neurochem Int. 57 4 2010 446 450
34. J. De Keyser, N. Wilczak, R. Leta, and C. Streetland Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors (Nov 10) Neurology 53 8 1999 1628 1633
35. V. del Gobbo, V. Libri, N. Villani, R. Caliò, and G. Nisticò Pinealectomy inhibits interleukin-2 production and natural killer activity in mice Int J Immunopharmacol. 11 5 1989 567 573
36. N.C. Derecki, J.C. Cronk, and J. Kipnis The role of microglia in brain maintenance: implications for Rett syndrome (Mar) Trends Immunol 34 3 2013 144 150
37. P. De Sarno, R.C. Axtell, C. Raman, K.A. Roth, D.R. Alessi, and R.S. Jope Lithium prevents and ameliorates experimental autoimmune encephalomyelitis J Immunol 1 2008 338 345
38. J.H. Dong, X. Chen, M. Cui, X. Yu, Q. Pang, and J.P. Sun Beta2-adrenergic receptor and astrocyte glucose metabolism (Oct) J Mol Neurosci. 48 2 2012 456 463
39. C. Ekmekcioglu Expression and putative functions of melatonin receptors in malignant cells and tissues Wien Med Wochenschr. 164 21-22 2014 472 478
40. B. Etain, A. Dumaine, F. Bellivier, C. Pagan, L. Francelle, and H. Goubran-Botros Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder (Sep 15) Hum Mol Genet. 21 18 2012 4030 4037
41. M.T. Fischer, R. Sharma, J.L. Lim, L. Haider, J.M. Frischer, and J. Drexhage NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury (Mar) Brain 135 Pt 3 2012 886 899
42. I. Fischer, C. Alliod, N. Martinier, J. Newcombe, C. Brana, and S. Pouly Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions PLoS One 6 8 2011 e23905
43. K.S. Fritz, J.J. Galligan, R.L. Smathers, J.R. Roede, C.T. Shearn, and P. Reigan 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification (May 16) Chem Res Toxicol. 24 5 2011 651 662
44. M. Fukuda, K.W. Williams, L. Gautron, and J.K. Elmquist Induction of leptin resistance by activation of cAMP-Epac signaling Cell Metab. 13 2011 331 339
45. E. Galecka, J. Szemraj, A. Florkowski, P. Galecki, and Karbownik-LewinskaM BiekiewiczM Single nucleotide polymorphisms and mRNA expression for melatonin MT(2) receptor in depression Psychiatry Res. 189 3 2011 472 474
46. G. Gergalova, O. Lykhmus, O. Kalashnyk, L. Koval, V. Chernyshov, and E. Kryukova Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria PLoS One 7 2 2012 e31361
47. M. Giralt, R. Ramos, A. Quintana, B. Ferrer, M. Erta, and M. Castro-Freire Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6 (Apr) Glia 61 4 2013 587 600
48. D. Golan, E. Staun-Ram, L. Glass-Marmor, I. Lavi, O. Rozenberg, and S. Dishon The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis (Aug) Brain Behav Immun. 32 2013 180 185
49. B.B. Gupta, L. Yanthan, and K.M. Singh In vitro effects of 5-hydroxytryptophan, indoleamines and leptin on arylalkylamine N-acetyltransferase (AA-NAT) activity in pineal organ of the fish, Clarias gariepinus (Burchell, 1822) during different phases of the breeding cycle. (Aug) Indian J Exp Biol. 48 8 2010 786 792
50. R. Hardeland, D.P. Cardinali, V. Srinivasan, D.W. Spence, G.M. Brown, and S.R. Pandi-Perumal Melatonin - a pleiotropic, orchestrating regulator molecule Prog Neurobiol. 93 2011 350 384
51. A.K. Hedström, T. Olsson, and L. Alfredsson High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women (Sep) Mult Scler. 18 9 2012 1334 1336
52. I. Herpfer, and K. Lieb Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders (Apr) World J Biol Psychiatr 4 2003 56 63
53. S. Hesse, F. Moeller, D. Petroff, D. Lobsien, J. Luthardt, and R. Regenthal Altered serotonin transporter availability in patients with multiple sclerosis (May) Eur J Nucl Med Mol Imaging. 41 5 2014 827 835
54. D. Horáková, M. Kýr, E. Havrdová, O. Doležal, P. Lelková, and L. Pospíšilová Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study Folia Biol (Praha) 56 6 2010 242 251
55. H. Hsuchou, P.K. Mishra, A.J. Kastin, X. Wu, Y. Wang, and S. Ouyang Saturable leptin transport across the BBB persists in EAE mice J Mol Neurosci. 51 2 2013 364 370
56. S.W. Jang, X. Liu, S. Pradoldeja, G. Tosini, Q. Chang, and P.M. Iuvone N-Acetylserotonin activates TrkB receptor in circadian rhythm PNAS 107 8 2010 3876 3881
57. J. Joscelyn, and L.H. Kasper Digesting the emerging role for the gut microbiome in central nervous system demyelination (Oct) Mult Scler. 20 12 2014 1553 1559
58. N.A. Kerenyi, P. Sotonyi, and E. Somogyi Localizing acetylserotonin transferase by electron microscopy Histochemistry 46 1975 77 80
59. J.M. Kim, R. Stewart, S.Y. Kim, S.W. Kim, K.Y. Bae, and S.J. Yang Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia (Sep) Int J Geriatr Psychiatry 26 9 2011 893 898
60. L. Kraszula, A. Jasińska, M. Eusebio, P. Kuna, A. Głąbiński, and M. Pietruczuk Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis (Jan-Feb) Neurol Neurochir Pol. 46 1 2012 22 28
61. P.J. Lardone, J.M. Guerrero, J.M. Fernández-Santos, A. Rubio, I. Martín-Lacave, and A. Carrillo-Vico Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor (Nov) J Pineal Res. 51 4 2011 454 462
62. D.H. Lee, E. Geyer, A.C. Flach, K. Jung, R. Gold, and A. Flügel Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination (Feb) Acta Neuropathol. 123 2 2012 247 258
63. S.E. Lee, S.J. Kim, J.-P. Youn, S.Y. Hwang, C.-S. Park, and Y.S. Park MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect J. Pineal Res. 51 2011 345 352
64. Q.Q. Li, D.R. Burt, and C.T. Bever Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells (Jun) J Neurochem. 77 5 2001 1208 1217
65. G.J. Lin, S.H. Huang, S.J. Chen, C.H. Wang, D.M. Chang, and H.K. Sytwu Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases (May 31) Int J Mol Sci. 14 6 2013 11742 11766
66. D.T. Lioy, S.K. Garg, C.E. Monaghan, J. Raber, K.D. Foust, and B.K. Kaspar A role for glia in the progression of Rett's syndrome (Jun 29) Nature 475 7357 2011 497 500
67. Y.J. Liu, F.T. Meng, L. Wu, and J.N. Zhou Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells Neuro Endocrinol Lett 34 3 2013 236 240
68. Y.J. Liu, F.T. Meng, L.L. Wang, L.F. Zhang, X.P. Cheng, and J.N. Zhou Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells (May) J Pineal Res. 52 4 2012 397 402
69. Y.J. Liu, J. Zhuang, H.Y. Zhu, Y.X. Shen, Z.L. Tan, and J.N. Zhou Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm (Oct) J Pineal Res. 43 3 2007 232 238
70. S. Ljubisavljevic, I. Stojanovic, D. Pavlovic, M. Milojkovic, D. Sokolovic, and I. Stevanovic Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis Folia Neuropathol. 51 1 2013 51 57
71. E. Luchowska, R. Kloc, B. Olajossy, S. Wnuk, M. Wielosz, and B. Owe-Larsson Beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signalling Prog. Neuropsychopharmacol. Biol Psychiatry. 33 3 2009 519 529
72. X. Ma, J. Zhou, Y. Zhong, L. Jiang, P. Mu, and Y. Li Expression, regulation and function of microRNAs in multiple sclerosis (Jun 2) Int J Med Sci. 11 8 2014 810 818
73. M. Maes, and W. Rief Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway Psychiatry Res. 196 2012 243 249
74. M. Maes, B.E. Leonard, A.M. Myint, M. Kubera, and R. Verkerk The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression (Apr 29) Prog Neuropsychopharmacol Biol Psychiatry. 35 3 2011 702 721
75. M. Maes, M. Kubera, E. Obuchowiczwa, L. Goehler, and J. Brzeszcz Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways Neuroendocrinol Lett 32 1 2011 7 24
76. D. Mahad, I. Ziabreva, H. Lassmann, and D. Turnbull Mitochondrial defects in acute multiple sclerosis lesions (Jul) Brain 131 Pt 7 2008 1722 1735
77. L.C. Manchester, B. Poeggeler, F.L. Alvares, G.B. Ogden, and R.J. Reiter Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system Cell Mol Biol Res 41 1995 391 395
78. J.M. Mariadason, A. Catto-Smith, and P.R. Gibson Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats (Mar) Gut 44 3 1999 394 399
79. R.P. Markus, C.L. Silva, D.G. Franco, E.M. Barbosa Jr, and Z.S. Ferreira Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs? (Jun) Pharmacol Ther 126 3 2010 251 262
80. E. Maronde, A. Saade, K. Ackermann, H. Goubran-Botros, C. Pagan, and R. Bux Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland (Aug) J Pineal Res. 51 1 2011 145 155
81. F. Mashayekhi, Z. Salehi, and H.R. Jamalzadeh Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis Acta Medica (Hradec Kralove) 55 2 2012 83 86
82. G. Matarese, P.B. Carrieri, A. La Cava, F. Perna, V. De Rosa, and D. Aufiero Leptin increase in multiple sclerosis associates with reduced number of CD4CD25 regulatory T cells PNAS 102 2005 5150 5155
83. L. Melamud, D. Golan, R. Luboshitzky, I. Lavi, and A. Miller Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis (Mar 15) J Neurol Sci 314 1-2 2012 37 40
84. I.L. Mero, C. Smestad, B.A. Lie, Å.R. Lorentzen, L. Sandvik, and N.I. Landrø Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course (Mar) J Neuroimmunol. 244 1-2 2012 107 110
85. A.L. Metti, J.A. Cauley, A.B. Newman, H.N. Ayonayon, L.C. Barry, and L.M. Kuller Plasma beta amyloid level and depression in older adults (Jan) J Gerontol A Biol Sci Med Sci 68 1 2013 74 79
86. M. Michaud, L. Balardy, G. Moulis, C. Gaudin, C. Peyrot, and B. Vellas Proinflammatory cytokines, aging, and age-related diseases (Dec) J Am Med Dir Assoc. 14 12 2013 877 882
87. A. Michels, M. Multhammer, M. Zintl, M.C. Mendoza, and H.H. Klünemann Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms J Alzheimers Dis 28 1 2012 25 32
88. E. Miller, A. Walczak, I. Majsterek, and J. Kędziora Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course (Apr 15) J Neuroimmunol 257 1-2 2013 97 101
89. P.K. Mishra, H. Hsuchou, S. Ouyang, A.J. Kastin, X. Wu, and W. Pan Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis (Nov) Brain Behav Immun. 34 2013 98 107
90. A. Mishra, S. Paul, and S. Swarnakar Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice (May) Biochimie 93 5 2011 854 866
91. Y. Miyazaki, R. Li, A. Rezk, H. Misirliyan, C. Moore, and N. Farooqi CIHR/MSSC new emerging team grant in clinical autoimmunity; MSSRF Canadian B cells in MS team. A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis (Aug 19) PLoS One 9 8 2014 e105421
92. C.S. Moore, R. Milner, A. Nishiyama, R.F. Frausto, D.R. Serwanski, and R.R. Pagarigan Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination (Apr 20) J Neurosci. 31 16 2011 6247 6254
93. B. Moreno, J.P. Jukes, N. Vergara-Irigaray, O. Errea, P. Villoslada, and V.H. Perry Systemic inflammation induces axon injury during brain inflammation (Dec) Ann Neurol. 70 6 2011 932 942
94. S. Mukda, M. Møller, M. Ebadi, and P. Govitrapong The modulatory effect of substance P on rat pineal norepinephrine release and melatonin secretion (Sep 25) Neurosci Lett. 461 3 2009 258 261
95. K.L. Munger, T. Chitnis, and A. Ascherio Body size and risk of MS in two cohorts of US women Neurology 73 2009 1543 1550
96. V. Murta, and C.C. Ferrari Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models (Mar) Mol Cell Neurosci. 53 2013 6 13
97. T. Musgrave, C. Benson, G. Wong, I. Browne, G. Tenorio, and G. Rauw The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE) (Nov) Brain Behav Immun. 25 8 2011 1677 1688
98. S.M. Muxel, M.A. Pires-Lapa, A.W.A. Monteiro, E. Cecon, E.K. Tamura, and L.M. Floeter-Winter NF-kB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene PLoS One 7 12 2012 e52010
99. D. Nanavati, D.R. Austin, L.A. Catapano, D.A. Luckenbaugh, A. Dosemeci, and H.K. Manji The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome (Nov) J Neurochem. 119 3 2011 617 629
100. R. Natarajan, E. Einarsdottir, A. Riutta, S. Hagman, M. Raunio, and N. Mononen Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients (Sep 15) J Neuroimmunol. 250 1-2 2012 106 110
101. H. Noda, H. Takeuchi, T. Mizuno, and A. Suzumura Fingolimod phosphate promotes the neuroprotective effects of microglia (Mar 15) J Neuroimmunol. 256 1-2 2013 13 18
102. K. Noguchi, and J. Chun Roles for lysophospholipid S1P receptors in multiple sclerosis (Feb) Crit Rev Biochem Mol Biol. 46 1 2011 2 10
103. K. Nowak, C. Lange-Dohna, U. Zeitschel, A. Günther, B. Lüscher, and A. Robitzki The transcription factor Yin Yang 1 is an activator of BACE1 expression (Mar) J Neurochem. 96 6 2006 1696 1707
104. Parada E., Buendia I., León R., Negredo P., Romero A., Cuadrado A., et al.Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. J Pineal Res. in press.
105. C. Pioli, M.C. Caroleo, G. Nistico, and G. Doria Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation Int J Immunopharmacol 15 1993 463 468
106. G.N. Pontes, E.C. Cardoso, M.M. Cameiro-Sampaio, and R.P. Markus Pineal melatonin and the innate immune response: the TNF-alpha increase after Cesarean sections suppresses nocturnal melatonin production J Pineal Res. 43 2007 365 371
107. N. Pozdeyev, C. Taylor, R. Haque, S.S. Chaurasia, A. Visser, and A. Thazyeen Photic regulation of arylalkylamine N-acetyltransferase binding to 14-3-3 proteins in retinal photoreceptor cells (Sep 6) J Neurosci 26 36 2006 9153 9161
108. R. Pul, F. Morbiducci, J. Skuljec, T. Skripuletz, V. Singh, and U. Diederichs Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients PLoS One 7 12 2012 e51867
109. N.T. Raikhlin, and I.M. Kvetnoy Melatonin and enterochromaffine cells Acta Histochem. 55 1 1976 19 24
110. E.K. Reinke, M.J. Johnson, C. Ling, J. Karman, J. Lee, and J.V. Weinstock Substance P receptor mediated maintenance of chronic inflammation in EAE (Nov) J Neuroimmunol. 180 1-2 2006 117 125
111. J. Robertson, J. Curley, J. Kaye, J. Quinn, T. Pfankuch, and J. Raber apoE isoforms and measures of anxiety in probable AD patients and Apoe-/-mice Neurobiol Aging. 26 5 2005 May 637 643
112. L. Ryan, K. Walther, B.B. Bendlin, L.F. Lue, D.G. Walker, and E.L. Glisky Age-related differences in white matter integrity and cognitive function are related to APOE status (Jan 15) NeuroImage 54 2 2011 1565 1577
113. S. Sathornsumetee, D.B. McGavern, D.R. Ure, and M. Rodriguez Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis Am J Pathol 157 2000 1365 1376
114. A. Schneider, S.A. Long, K. Cerosaletti, C.T. Ni, P. Samuels, and M. Kita In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling (Jan 30) Sci Transl Med 5 170 2013 170ra15
115. S. Serada, M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi, and S. Nomura IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis (Jul 1) PNAS 105 26 2008 9041 9046
116. R. Sharma, T. Ottenhof, P.A. Rzeczkowska, and L.P. Niles Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells (Oct) J Pineal Res 45 3 2008 277 284
117. J. Sheffler, J. Moxley, and N. Sachs-Ericsson Stress, race, and APOE: understanding the interplay of risk factors for changes in cognitive functioning Aging Ment Health. 18 6 2014 784 791
118. J. Shi, J. Tu, S.D. Gale, L. Baxter, T.L. Vollmer, and D.I. Campagnolo APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis (Sep) Cogn Behav Neurol. 24 3 2011 128 133
119. P.A. Singleton, S.M. Dudek, E.T. Chiang, and J.G. Garcia Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin (Oct) FASEB J. 19 12 2005 1646 1656
120. A. Sommansson, W.S. Saudi, O. Nylander, and M. Sjöblom Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo (Jul 1) Am J Physiol Gastrointest Liver Physiol. 305 1 2013 G95 G105
121. F. Song, M. Bandara, H. Deol, J.A. Loeb, J. Benjamins, and R.P. Lisak Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors (Sep 15) J Neuroimmunol. 262 1-2 2013 11 18
122. Y.M. Song, and M.D. Chen Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice (Dec) Acta Biol Hung. 60 4 2009 399 407
123. K.A. Stokkan, and R.J. Reiter Melatonin rhythms in Arctic urban residents (Jan) J Pineal Res. 16 1 1994 33 36
124. S. Stuebe, T. Wieland, E. Kraemer, Stritzky Av, D. Schroeder, and S. Seekamp Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene (Jan) Naunyn Schmiedebergs Arch Pharmacol. 376 5 2008 363 373
125. S.H. Tai, H.Y. Chen, E.J. Lee, T.Y. Chen, H.W. Lin, and Y.C. Hung Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia (Nov) J Pineal Res. 49 4 2010 332 341
126. Y. Tamam, N. Tasdemir, M. Yalman, and B. Tamam Association of apolipoprotein E genotypes with prognosis in multiple sclerosis (Oct) Eur Rev Med Pharmacol Sci. 15 10 2011 1122 1130
127. D.X. Tan, L.C. Manchester, X. Liu, S.A. Rosales-Corral, D. Acuna-Castroviejo, and R.J. Reiter Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes J. Pineal Res. 54 2013 127 138
128. C.A. Tegla, P. Azimzadeh, M. Andrian-Albescu, A. Martin, C.D. Cudrici, and R. Trippe 3rd SIRT1 is decreased during relapses in patients with multiple sclerosis (Apr) Exp Mol Pathol. 96 2 2014 139 148
129. M.W. Tham, P.S. Woon, M.Y. Sum, T.S. Lee, and K. Sim White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies (Jul) J Affect Disord. 132 1-2 2011 26 36
130. H. Toft-Hansen, L. Füchtbauer, and T. Owens Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease (Jan) Glia 59 1 2011 166 176
131. A.F. Tyler, J.P. Mendoza, M. Firan, and N.J. Karandikar CD8+ T cells are required for Glatiramer acetate therapy in autoimmune demyelinating disease (Jun 21) PLoS One 8 6 2013 e66772
132. R. van Doorn, P.G. Nijland, N. Dekker, M.E. Witte, M.A. Lopes-Pinheiro, and B. van het Hof Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes (Sep) Acta Neuropathol. 124 3 2012 397 410
133. T. Vanuytsel, S. van Wanrooy, H. Vanheel, C. Vanormelingen, S. Verschueren, and E. Houben Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism (Aug) Gut 63 8 2014 1293 1299
134. S. Villapol, S. Fau, S. Renolleau, V. Biran, C. Charriaut-Marlangue, and O. Baud Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke (Jan) Pediatr Res. 69 1 2011 51 55
135. P. Wang, K. Xie, C. Wang, and J. Bi Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis (Sep 30) Eur Neurol. 72 3-4 2014 249 254
136. X. Wang, A. Sirianni, Z. Pei, K. Cormier, K. Smith, and J. Jiang The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity J Neurosci. 31 2011 14496 14507
137. A. Waschbisch, M. Atiya, R.A. Linker, S. Potapov, S. Schwab, and T. Derfuss Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis PLoS One 6 9 2011 e24604
138. I. Wens, U. Dalgas, E. Stenager, and B.O. Eijnde Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review (Oct) Mult Scler. 19 12 2013 1556 1564
139. A.W. Wong, J. Xiao, D. Kemper, T.J. Kilpatrick, and S.S. Murray Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation (Mar 13) J Neurosci. 33 11 2013 4947 4957
140. J.M. Woodcock, Y. Ma, C. Coolen, D. Pham, C. Jones, and A.F. Lopez Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function Cell Signal. 22 2010 1291 1299
141. B. Wootla, M. Eriguchi, and M. Rodriguez Is multiple sclerosis an autoimmune disease? Autoimmune Dis 2012 2012 969657
142. C. Wu, S.Y. Leong, C.S. Moore, Q.L. Cui, P. Gris, and L.P. Bernier Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation (Mar 19) J Neuroinflammation 2013 10 41
143. Z. Xiao, J. Wang, W. Chen, P. Wang, H. Zeng, and W. Chen Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease (Nov 26) Lipids Health Dis. 2012 11 163
144. C. Xuan, B.B. Zhang, M. Li, K.F. Deng, T. Yang, and X.E. Zhang No association between APOE ε 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls (Sep 15) J Neurol Sci. 308 1-2 2011 110 116
145. D.Y. Yoo, S.M. Nam, W. Kim, C.H. Lee, M.H. Won, and I.K. Hwang N-Acetylserotonin increases cell proliferation and differentiating neuroblasts with tertiary dendrites through upregulation of brain-derived neurotrophic factor in the mouse dentate gyrus J Vet Med Sci. 73 11 2011 1411 1416
146. S. Yoshimura, H. Ochi, N. Isobe, T. Matsushita, K. Motomura, and T. Matsuoka Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis (Oct) Mult Scler. 16 10 2010 1178 1188
147. Z. Zhang, Z.Y. Zhang, Y. Wu, and H.J. Schluesener Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats (Sep 27) Neuroscience 2012 140 150 221 2012 140 150
148. H.Q. Zhu, Q. Li, L.Y. Dong, Q. Zhou, H. Wang, and Y. Wang MicroRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression (Oct 20) Int J Cardiol. 176 3 2014 764 770
149. A.E. Zubidat, and A. Haim The effect of alpha- and beta-adrenergic blockade on daily rhythms of body temperature, urine production, and urinary 6-sulfatoxymelatonin of social voles Microtus socialis (Oct) Comp Biochem Physiol A Mol Integr Physiol 148 2 2007 301 307